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Purpose: The purpose of this study was to evaluate bone formation around recombinant 
human bone morphogenetic protein (rhBMP-2)-coated implants placed with or without 
absorbable collagen sponge (ACS) in rabbit maxillary sinuses.
Methods: The Schneiderian membrane was elevated and an implant was placed in 24 si-
nuses in 12 rabbits. The space created beneath the elevated membrane was filled with ei-
ther blood (n=6) or ACS (n=6). In the rabbits in which this space was filled with blood, rh-
BMP-2-coated and non-coated implants were alternately placed on different sides. The re-
sulting groups were referred to as the BC and BN groups, respectively. The AC and AN 
groups were produced in ACS-grafted rabbits in the same manner. Radiographic and histo-
morphometric analyses were performed after eight weeks of healing.
Results: In micro-computed tomography analysis, the total augmented volume and new 
bone volume were significantly greater in the ACS-grafted sinuses than in the blood-filled 
sinuses (P<0.05). The histometric analysis showed that the areas of new bone and bone-
to-implant contact were significantly larger in the AC group than in the AN group 
(P<0.05). In contrast, none of the parameters differed significantly between the BC and BN 
groups.
Conclusions: The results of this pilot study indicate that the insertion of ACS after elevat-
ing the Schneiderian membrane, simultaneously with implant placement, can significantly 
increase the volume of the augmentation. However, in the present study, the rhBMP-2 
coating exhibited limited effectiveness in enhancing the quantity and quality of regenerat-
ed bone.
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INTRODUCTION
Sinus augmentation using bone substitute materials is a well-documented procedure for 
implant placement in posterior maxillae that have undergone severe resorption, and it has 
shown clinically predictable outcomes with success rates exceeding 90% in meta-analyses 
[1,2]. However, placing bone substitute under the elevated Schneiderian membrane is bur-
densome, time-consuming, and costly. Using a bone substitute may be indispensable for 
volume maintenance, but it may retard the healing process [3,4] and result in a significant 
delay before mature new bone is incorporated.
Several modifications have been attempted with the goal of overcoming those difficulties 
[5-7]. Lundgren et al. [8] suggested performing sinus augmentation with blood coagulum 
and simultaneous implant placement. Their protocol included stabilizing the elevated 
This is an Open Access article distributed under the terms 
of the Creative Commons Attribution Non-Commercial 
License (http://creativecommons.org/licenses/by-nc/3.0/).
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Schneiderian membrane by suturing, with the holes made on the 
superior bony surface of the window and on the window sealed by 
repositioning a bone fragment. The use of non-material sinus aug-
mentation with simultaneous implant placement in subsequent 
studies showed substantial bone formation; the extent of osseoin-
tegration was found to be as high as that observed in autogenous 
bone grafting in both primates [9] and humans (survival rate=98.7%; 
new bone height [NBH]=5.3±2.1 mm in a six-year clinical study) 
[10]. Several studies have also found comparable survival rates for 
implants with non-material and material-grafted sinus augmenta-
tion [11-14]. However, the extent of the increases in NBH varied, and 
the implant apex was not completely covered in most implants (189 
of 239) [10,15]. In addition, it has been found that implants extend-
ing into the sinus cavity can cause iatrogenic sinusitis and are associ-
ated with the risk of migration into the cavity [16,17]. Such unpre-
dictable outcomes could potentially hinder the widespread use of 
this technique.
Growth factors have been used to enhance the osteogenic pro-
cess around the implant surfaces. Recombinant human bone mor-
phogenetic protein (rhBMP-2) has been used to coat the implant 
surfaces in order to facilitate local bone formation [18-20]. Using 
the implant itself as a delivery system for rhBMP-2 could be ad-
vantageous both in terms of minimizing the loss of the growth 
factor during the surgical procedure and for localizing it at the 
surgical site [21,22], as well as involving a lower dose of rhBMP-2 
and thereby minimizing the complications associated with high 
doses of rhBMP-2 [23,24].
The presence of an rhBMP-2 coating on implant surfaces has 
been reported to accelerate new bone formation at the supra-al-
veolar level in canine mandibles [21,25]. Definite differences are 
present between the sinus augmentation model and the ridge 
augmentation model in terms of the surrounding anatomy and 
the biomechanics. Ridge and sinus augmentation involve adding 
bone to the coronal and apical dimensions, respectively, and both 
involve vertical bone gain along the implant. To the best of our 
knowledge, no previous study has evaluated the effect of rhBMP-
2-coated implants on sinus augmentation.
The purpose of this study was to evaluate bone formation around 
rhBMP-2-coated implants placed with or without absorbable colla-
gen sponge (ACS) in rabbit maxillary sinuses. The ACS was inserted 
with the objective of achieving blood clot stabilization.
 
MATERIALS AND METHODS
Animals
Twelve male New Zealand white rabbits weighing 2.8–3.2 kg were 
used in this study. Animal selection and management, the surgical 
protocol, and the operative procedures were approved by the Insti-
tutional Animal Care and Use Committee, Yonsei Medical Center, 
Seoul, South Korea (IACUC Approval No. 2012-0327). The animals 
were kept in separate cages under standard laboratory conditions, 
with free access to water and a standard laboratory pellet diet.
Study design
The animals were divided into the blood-filled and ACS-grafted 
groups (each n=6). In each group, rhBMP-2-coated and non-
coated implants were alternately applied to the two sinuses, re-
sulting in the following four groups:
1. BN group: non-coated implant placed in the blood-filled sinus.
2.  BC group: rhBMP-2-coated implant placed in the blood-filled 
sinus.
3. AN group: non-coated implant placed in the ACS-grafted sinus.
4.  AC group: rhBMP-2-coated implant placed in the ACS-grafted 
sinus.
Experimental materials
Experimental mini-implants
Custom-made mini-implants were used in this study (Genoss, 
Suwon, Korea). They were cylindrical in shape (6 mm long and 3 
mm in diameter) with screw threads for initial fixation that cov-
ered a quarter of the coronal portion (1.5 mm from the top of the 
implant), and the implants had a sand-blasted, large grit, acid-
etched surface. The rhBMP-2 was coated on the cylindrical area 
away from the threads so that it remained in place during installa-
tion (Figure 1).
rhBMP-2 coating on mini-implants
The sterilized implants were coated with rhBMP-2 (Genoss, Su-
won, Korea). Lyophilized rhBMP-2 in sodium acetate buffer (20 
mM sodium acetate, pH 4.0; Sigma, St. Louis, MO, USA) was kept 
refrigerated at 4°C until use. Under aseptic conditions, the rh-
BMP-2 solution was reconstituted to a 2.0 mg/mL liquid concen-
tration with 2% hyaluronic acid in sodium acetate buffer. The im-
A
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Figure 1. Custom-made mini-implants and micrographs of their surfaces 
with and without a recombinant human bone morphogenetic protein (rh-
BMP)-2 coating. (A) Schematic of the mini-implant (length, 6.0 mm; diame-
ter, 3.0 mm), which had a sandblasted, large grain, acid-etched surface and 
included a 1.5-mm threaded portion in the coronal area for fixation and a 
4.5-mm cylindrical portion that was coated with rhBMP-2. (B) Scanning 
electron microscopy (SEM) scan of the uncoated surface in the threaded area. 
(C) SEM scan of the rhBMP-2-coated surface in the cylindrical area.
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plants were placed in sterile 0.5-mL wells (96 Stripwell plate, round 
well polypropylene, Sigma) that were filled with the 2.0 mg/mL rh-
BMP-2 solution (net volume of solution, 0.05 mL per implant) and 
incubated for 30 minutes. The implants were then air-dried for 16 
hours. All of these procedures were performed in a biological safe-
ty cabinet (Airstream, Class II, A2 type; Esco, Philadelphia, PA, USA) 
at room temperature.
Surgical procedure
All surgical procedures were performed by a single experienced 
surgeon (U.W.J.). Under general anesthesia, additional infiltrative 
anesthesia was applied to the surgical site in the middle portion of 
the nasal dorsum. The surgical field was then disinfected with io-
dine-soaked cotton wool. An incision was made along the midline, 
including the skin and periosteum. The resultant full-thickness flaps 
were lifted and the nasal bone was exposed for the next procedure. 
Two identical circular windows were prepared bilaterally using a 
trephine bur with a diameter of 5.5 mm (C-reamer, Neobiotech, 
Seoul, Korea), and the Schneiderian membrane was elevated care-
fully to a position 10 mm anterior from the window margin. The 
implant sites were prepared 3 mm in front of the windows using a 
pilot drill bit followed by a final drill bit (2.7 mm in diameter), with 
a surgical curette inserted into the window in order to protect the 
Schneiderian membrane from the drilling process. Before setting 
the mini-implants, prepared blood obtained from the branchial 
vein of an ear was applied to both sides (n=6) or ACS soaked with 
blood was inserted (n=6). One rhBMP-2-coated implant (diameter 
3 mm, length 6 mm; Genoss) was placed by manual force in one si-
nus, while a non-coated implant for the control group was placed 
in the contralateral sinus. The groups were allocated alternately in 
consecutive rabbits. After completing all surgical procedures, the 
bony windows were replaced and covered by periosteum. The peri-
osteum and skin were closed layer by layer with glyconate absorb-
able monofilament (6-0 Monosyn, B-Braun, Aesculap, Allentown, 
PA, USA). Nonsteroidal anti-inflammatory drugs (0.5 mg/kg of ke-
torolac, intravenously) were administered once for pain control af-
ter surgery. Broad-spectrum antibiotics (5 mg/kg of enrofloxacin, 
subcutaneously, twice per day for five days) were administered for 
infection control. All rabbits were raised in individually assigned 
cages and received food and water ad libitum. The temperature 
and humidity were maintained at 20°–22°C and 40%–60%, respec-
tively. The sutures were removed 10 days postoperatively under se-
dation. The rabbits were sacrificed by an overdose of anesthesia af-
ter eight weeks of healing.
Radiographic analysis: micro-computed tomography
All specimens were fixed in 10% formalin for 10 days and scanned 
with a high-resolution micro-computed tomography (micro-CT) sys-
tem (SkyScan 1173, SkyScan, Aartselaar, Belgium) at a resolution of 
9 μm (using settings of 130 kV and 60 μA) with a 0.25-mm bromine 
filter. One experienced researcher measured the data while blinded 
to the group assignments using CT Analyzer 1.14 (Bruker-CT, Kon-
tich, Belgium). The total augmented volume (TV; mm3) and the new-
ly formed bone volume (NBV; mm3) were measured. New bone was 
identified in images as pixels with grayscale values of 55–255 
[24,26]. The new bone density (NDV) was calculated as the NBV di-
vided by the TV.
Histologic and histomorphometric analyses
After micro-CT scanning, the specimens were dehydrated in eth-
anol, embedded in methacrylate, and sectioned along the long axis 
of the mini-implants using a diamond saw (Exakt, Apparatebau, 
Norderstedt, Germany). The final thickness of the specimens was 
reduced to about 20 μm. They were stained with hematoxylin and 
eosin and analyzed histologically using a microscope. Digital imag-
es of the histologic slides were obtained using a built-in digital 
camera in the light microscope (BX50, Olympus, Tokyo, Japan).
The following linear measurements were made by a single expe-
rienced examiner (W.S.B.) twice, at a three-week interval, based on 
the methodology of a previous study [27]. The following parame-
ters were measured:
1.  Cortical bone thickness (CBT), reflecting the thickness of native 
bone close to the bony window;
2.  NBH, which was the distance from the inner border of cortical 
bone to the most apical level of new bone on the implant sur-
face;
3.  Exposed height (EH), which was the distance between the most 
apical level of new bone and the horizontal line at the tip of the 
mini-implant;
4.  Protruding height (PH), which was the length of the implant 
protruding into the sinus cavity;
5.  Bone-to-implant contact ratio (BIC), which was the percentage 
of new bone in contact with the implant surface.
These measurements were performed on both the medial and lat-
eral sides of the implants.
A rectangular area of interest (AOI) was selected adjacent to the 
implant (1.5 mm in width, and as long as the implant plus 1.5 mm 
apical to the implant apex in height). The following parameters 
were measured in the AOIs in the medial and lateral areas of the 
implants: total augmented area (TA; mm2), new bone area (NBA; 
mm2), fibrovascular tissue area (FVA; mm2), and new bone density 
(NDA) (Figure 2).
Statistical analysis
Statistical analysis was performed using SPSS version 15.0 (SPSS, 
Chicago, IL, USA). The intraexaminer coefficient between the pa-
rameters measured at a three-week interval was 0.98 (P<0.05). 
Due to the small number of samples, statistical significance was 
analyzed using the following nonparametric tests: the Wilcoxon 
signed-rank test for the BC group versus the BN group and for the 
AC group versus the AN group, and the Mann-Whitney U test for 
the BC group versus the AC group and for the BN group versus the 
AN group. The cutoff for statistical significance was set at P<0.05.
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RESULTS
Clinical observations
Seven minor perforations (<2 mm) occurred during surgery, at 
two sites in the BC, BN, and AC groups, and at one site in the AN 
group. No postoperative complications, such as pus discharge or 
swelling, were found in any of the rabbits. After euthanizing the 
animals, implant exposure beyond the Schneiderian membrane 
and implant displacement were not observed.
Radiographic analysis: micro-CT
New bone appeared in a wide-dome shape in the ACS-grafted 
group and in a thin-pyramid shape in the blood-filled group. New 
bone formation was greater on the lateral side of the implant than 
on the medial side. The presence or absence of the rhBMP-2 coat-
ing had no noticeable effect on the patterns of bone formation 
(Figure 3).
The TV was significantly greater in the ACS-grafted groups than 
in the blood-filled groups. The TV differed significantly between the 
Figure 4. Mean values of the total augmented volume (TV) and newly formed bone volume (NBV) beneath the elevated Schneiderian membrane in micro-com-
puted tomography analysis (n=6, respectively). (A) TV, (B) NBV, (C) new bone density (NDV). 
*, significant difference, P<0.05.
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Figure 2. Parameters for the linear and areal measurements. The rectangle 
with the blue border indicates the area of interest (AOI). The subarea bordered 
by a dotted line indicates the total augmented area (TA). The orange dotted 
line dividing the AOI indicates the Schneiderian membrane. 
NBA, new bone area; PH, protruding height; NBH, new bone height; CBT, cor-
tical bone thickness; EH, exposed height.
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Figure 3. Three-dimensionally reconstructed images of representative micro-
computed tomography (micro-CT) views. Newly formed bone appears red, the 
mini-implant fixture appears green, and the nasal bone appears brown, with 
the internal surface of the implant facing upwards. (A, B) The newly formed 
bone had a pyramidal shape in the BN and BC groups. (C, D) The newly formed 
bone had a trapezoidal shape in the AN and AC groups. (A) The BN group, (B) 
the BC group, (C) the AN group, (D) the AC group. BC, blood-filled and coated 
implant; BN, blood-filled and non-coated implant; AC, absorbable collagen 
sponge and coated implant; AN, absorbable collagen sponge and non-coated 
implant.
ACS, absorbable collagen sponge; L, lateral; M, medial; A, anterior; P, posterior.
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AC and BC groups (157.01 ±38.29 mm3 vs. 90.47 ±41.61 mm3, 
P=0.016) and between the AN and BN groups (173.93±41.49 mm3 
vs. 65.18±24.95 mm3, P=0.004) (Figure 4A). The NBV was also sig-
nificantly greater in the ACS-grafted groups than in the blood-
filled groups: 33.48±11.94 mm3 in the AC group versus 7.60±4.40 
mm3 in the BC group (P=0.004), and 29.53±5.03 mm3 in the AN 
group versus 7.61±2.60 mm3 in the BN group (P=0.004). The NBV 
was greater in the AC group than in the AN group, but this differ-
A
B
C D
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F
Figure 5. Histologic images of representative sites after eight weeks of healing in the blood-filled group. (A): BN group. Bone formation in a pyramidal shape was 
observed. The red arrowhead indicates the outer boundary of the cortical bone layer, the yellow arrowhead indicates the inner boundary of the cortical bone lay-
er, the blue arrowhead indicates the apical margin of new bone height (NBH), and the white horizontal line indicates the most apical line meeting the fixture. (B) 
The coronal part adjacent to the top area of the implant. (C) The apical part around the end of the newly formed bone. A well-maintained Schneiderian mem-
brane was observed. (D) The BC group. (E) The coronal part adjacent to the top area of the implant. (F) The apical part around the end of the newly formed bone. 
NB, new bone.
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Figure 6. Histologic images of representative sites after eight weeks of healing in the ACS-grafted group. (A) The AN group. (B) The coronal part adjacent to the 
top area of the implant. (C) The apical part around the end of the newly formed bone. A well-maintained Schneiderian membrane was observed. Detached newly 
formed bone was seen on the apical margin of the new bone height (NBH). Newly formed bone had a relatively low density. (D) The AC group. (E) The coronal part 
adjacent to the top area of the implant. (F) The apical part around the end of the newly formed bone. A high bone-to-implant contact ratio (BIC) was observed. 
NB, new bone.
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ence did not reach statistical significance (Figure 4B). The NDV dif-
fered significantly between the AC and BC groups (21.77±6.81% 
vs. 8.28±2.37%, P=0.004) (Figure 4C).
Histologic observations
Neither inflammatory responses nor adverse foreign body reac-
tions were observed in the histological analysis. The new bone 
generally appeared to initially sprout from the basal bone toward 
the implant apex along the implant surface. New bone was more 
loosely scattered in the ACS-grafted group than in the blood-filled 
group. The Schneiderian membrane made direct contact with the 
apex of the implant in all except two implants in the AC group, in 
which it was completely surrounded by bone tissue (Figure 5C and 
F; 6B, C, E, and F).
The general shape of bone formation differed between the ACS-
grafted and blood-filled groups. Dense and lamellar bone in a tri-
angular shape with a steep angle was observed around the im-
plants in the BC and BN groups, whereas the newly formed bone 
exhibited a trapezoidal shape in the AC and AN groups. The pat-
tern of bone formation did not differ histologically between the 
BN and BC groups, with the new bone being in continuous contact 
with the implant surface (Figure 5B and E). The new bone was 
denser and more even in the AC group than in the AN group (Fig-
ure 6A and D), and it extended more continuously along the im-
plant surface in the AC group than in the AN group.
Histomorphometric analysis
Table 1 presents the mean (± standard deviation) values of the 
linear measurements. CBT did not differ significantly among the 
four groups. The NBH was highest in the AC group, but the differ-
ences did not reach statistical significance. The BIC was signifi-
cantly greater in the AC group than in the AN group, but did not 
Table 1. Linear measurements in the histometric analysis. The data are 
mean± standard deviation values (in millimeters) for averaged measurements 
on the medial and lateral sides.
Group BC BN AC AN
CBT (n=6) 0.66±0.20 0.54±0.18 0.52±0.14 0.48±0.08
NBH (n=6) 3.86±1.00 3.99±0.43 4.27±0.91 3.85±1.27
EH (n=6) 1.60±0.70 1.28±0.50 0.96±0.85 1.44±1.28
PH (n=6) 5.46±0.53 5.27±0.36 5.24±0.12 5.29±0.25
CBT, cortical bone thickness; NBH, new bone height; EH, exposed height; PH, protruding 
height; BC, blood-filled and coated implant; BN, blood-filled and non-coated implant; 
AC, absorbable collagen sponge and coated implant; AN, absorbable collagen sponge 
and non-coated implant.
No significant differences were observed among the groups.
Figure 7. Mean values of bone-to-implant contact (BIC), total augmented area (TA), newly formed bone area (NBA) and fibrovascular tissue area (FVA) in the 
area of interest in the histometric analysis (n=6, respectively). (A) BIC, (B) TA, (C) NBA, (D) FVA. 
*significant difference, P<0.05.
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differ significantly between the AC and BC groups (Figure 7A).
The measurements made in the AOIs are shown in Figure 7. The 
TA and FVA were significantly higher in the AC group than in the 
BC group, and in the AN group than in the BN group (P<0.01). The 
presence or absence of ACS did not significantly affect the NBA. 
The NBA was significantly greater in the AC group than in the AN 
group (4.10±1.10 mm2 vs. 3.08±0.70 mm2, P<0.05) (Figure 7B–D). 
The placing of non-coated implants significantly decreased the 
NDA in the ACS-grafted groups (48.10±9.76% in the BN group vs. 
29.15±11.54% in the AN group, P=0.015), whereas the placing of 
rhBMP-2-coated implants did not significantly affect the NDA 
(40.24±8.45% in the BC group vs. 32.76±11.88% in the AC group, 
P=0.262).
 
DISCUSSION
The maintenance of space under the elevated Schneiderian mem-
brane is critical for ensuring long-term stability following sinus 
augmentation. Despite the evidence for de novo bone formation in 
sinus augmentation without bone grafting, the quantity and quality 
of the regenerated bone have not previously been validated. In the 
present study, blood coagulum and ACS were used as space-filling 
matrices for the purpose of aiding the effects of rhBMP-2-coated 
implants.
Choi et al. [23] reported that inserting collagenous biomaterials 
under the Schneiderian membrane provided some degree of space 
maintenance during the early healing phase. However, inserting 
ACS alone into rabbit sinuses caused the generation of new bone 
with a thickness of about 2 mm. In the present study, the TV and 
NBV were significantly greater in the ACS-grafted groups than in 
the blood-filled groups. However, it should be noted that the ACS 
did not fully counteract the repneumatization. Although full cov-
erage with newly formed bone over the implant apex was ob-
served at two of the six sites in the AC group, EHs ranging from 
0.96 to 1.44 mm were observed in the ACS-grafted group. This 
finding closely reflects those of a previous report regarding modi-
fied sinus elevation surgery [27].
Longer mini-implants (6 mm) were used in the present study 
based on the results obtained by Jung et al. [27] using 4-mm mini-
implants. A positive correlation between the length of the implant 
and bone gain has been reported in non-material sinus augmenta-
tion [12]: compared to 9-mm implants, 15-mm implants showed a 
greater average bone gain (3.50 mm vs. 6.94 mm). Such “tenting” 
with a long implant against the Schneiderian membrane could in-
crease bone regeneration. The average value of the NBH in the BN 
group in the present study (3.99 mm) was 75% of the PH (5.27 
mm), whereas Jung et al. [27] found that the NBH was only 1.5 
mm when using a 4-mm implant, which was less than 50% of the 
PH (3.2 mm).
In the present study, the bony window was repositioned after 
the sinus augmentation procedure, unlike the previous mini-im-
plant study of Jung et al. [27]. The replacement of the bony win-
dow has previously been regarded as indispensable by researchers 
advocating the use of non-material sinus augmentation [7-9]. The 
window is intended to act as a barrier to prevent the blood coagu-
lum from being dislodged from the augmented sinus compartment 
and to re-establish pneumatic conditions [8]. The greater stability 
of the blood coagulum could stimulate mesenchymal progenitor 
cells and osteogenic cells in the surrounding tissue, thereby pro-
moting osteogenic differentiation [7,28]. This could explain why 
the NBH was more than six times greater (3.99 mm) than the orig-
inal bone thickness (0.54 mm) in the BN group.
Coating the implant surface with rhBMP-2 was expected to re-
sult in more favorable bone formation overall and along the im-
plant surface, regardless of the presence of a space filler. However, 
combining rhBMP-2 coating with blood filling did not produce a 
discernible effect. Moreover, in combination with ACS, nonsignifi-
cant increases in the NBV and NDV were observed in the AC group 
in comparison with the AN group, although the NBV and NDV 
were greater than in the blood-filled group. These findings may 
have been due to the space-maintaining function of ACS being a 
more important factor for bone regeneration. However, the ten-
dency for bone formation near the Schneiderian membrane was 
greater in the AC group, in agreement with previous observations 
of the osteogenic potential of the Schneiderian membrane under 
the influence of rhBMP-2 [29-31].
Coating the implant with rhBMP-2 improved the BIC in the AC 
group in comparison to the AN group. The BIC in the AN group 
decreased by approximately 15%. In other studies using rhBMP-
2-coated implants, a BIC value of 37.4% was found in the sinus of 
a mini-pig [32], and values of 28%–36.8% were reported for su-
pra-alveolar defects in dogs [33]. These differences may have been 
due to the use of different animals and experimental models, as 
well as the small sample sizes.
No previous study has evaluated rhBMP-2-coated implants in a 
rabbit sinus model. Choi et al. [31] found that adding 0.15 mg of 
rhBMP-2 to a coating of biphasic calcium phosphate did not sup-
port sinus augmentation in rabbits, which prompted the use of a 
lower total dose to 0.1 mg in this pilot study. Kim et al. [34] found 
that 0.015 mg of rhBMP-2 was not sufficient to induce a statisti-
cally significant effect in a similar model. While no adverse events 
were noted when that dose was used, the bone regeneration asso-
ciated with the rhBMP-2-coated implants did not significantly 
differ from what was observed in other groups. Therefore, increas-
ing the amount of newly formed bone and the bone density most 
likely requires further adjustment of the rhBMP-2 concentration.
Based on the results of this study, it can be concluded that the 
insertion of ACS following the elevation of the Schneiderian mem-
brane and simultaneously with implant placement can significant-
ly increase the augmented volume. However, the use of rhBMP-2 
coating in the present study had limited effects in terms of en-
hancing the quantity and quality of regenerated bone.
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